Larson Financial Group’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,138
Closed -$4.77K 3450
2025
Q1
$4.77K Hold
1,138
﹤0.01% 1896
2024
Q4
$5.49K Hold
1,138
﹤0.01% 1643
2024
Q3
$4.19K Hold
1,138
﹤0.01% 1703
2024
Q2
$4.61K Hold
1,138
﹤0.01% 1465
2024
Q1
$5.45K Hold
1,138
﹤0.01% 1180
2023
Q4
$8.6K Sell
1,138
-150
-12% -$1.23K ﹤0.01% 1055
2023
Q3
$13.2K Buy
1,288
+1,178
+1,071% +$14.5K ﹤0.01% 923
2023
Q2
$1.52K Sell
110
-98
-47% -$1.47K ﹤0.01% 1314
2023
Q1
$3.38K Buy
208
+1
+0.5% +$19 ﹤0.01% 1157
2022
Q4
$3.66K Buy
207
+2
+1% +$40 ﹤0.01% 1089
2022
Q3
$4K Sell
205
-19
-8% -$403 ﹤0.01% 1005
2022
Q2
$4K Sell
224
-316
-59% -$7.06K ﹤0.01% 912
2022
Q1
$14K Buy
540
+9
+2% +$233 ﹤0.01% 585
2021
Q4
$13K Buy
+531
New +$14.7K ﹤0.01% 620

Other funds holding PETS

Larson Financial Group's PETS Position: Q2 2025 in Review

Larson Financial Group sold out of PetMed Express (PETS) in Q2 2025, closing a stake of 1,138 shares — an estimated $4.77K sold.

Larson Financial Group first reported a position in PETS in Q4 2021 and held it in 14 quarters. The position peaked at $14K in Q1 2022. 64 funds tracked by Wall St. Rank hold PETS as of Q2 2025.

  • Larson Financial Group reported no remaining PetMed Express position as of Q2 2025 after selling out during the quarter.
  • Larson Financial Group sold 1,138 PetMed Express shares in Q2 2025, an estimated $4.77K.
  • Larson Financial Group first reported a position in PetMed Express in Q4 2021 and held it in 14 quarters.
  • Larson Financial Group's PetMed Express position peaked at $14K in Q1 2022.
  • 64 funds tracked by Wall St. Rank held PetMed Express as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.